Instituto de Oncologia do Paraná

What Instituto de Oncologia do Paraná does

Instituto de Oncologia do Paraná (IOP) is a private, for-profit oncology clinic founded in 1995 and headquartered in Curitiba, Brazil, operating as part of the Grupo MED4U healthcare conglomerate under CEO Ronaldo Amorim. It is the first chemotherapy clinic established in Curitiba and has grown to four physical locations across the city (Mateus Leme, Batel, Oncoville/Mossunguê, and the Câncer Center inside Hospital São Marcelino Champagnat), serving cancer patients across Paraná and Southern Brazil.

IOP delivers a comprehensive oncology platform spanning chemotherapy, surgical oncology, radiotherapy (via subsidiary Oncoville), immunotherapy, targeted therapy, hematology, mastology, palliative care, and supportive services including psycho-oncology, nutritional oncology, physiotherapy, and oncology pharmacy. It maintains a Centro de Pesquisa Clínica participating in global oncology trials and offers infusion therapies for autoimmune diseases. The clinic holds ONA 3 "Acreditado com Excelência" accreditation and is the first Southern Brazil clinic integrated into the Rede Einstein de Oncologia e Hematologia.

IOP generates revenue from per-episode clinical services and health insurance (convênios) contracts, supplemented by clinical trial participation and, as of May 2025, a postgraduate oncology education program (IOP Educa) operated in partnership with PUCPR. It markets directly to patients through a content-rich website, WhatsApp booking, online scheduling, social media, its own podcast (Aqui por Você), and community awareness campaigns. The customer base is fragmented across individual patients, with no single enterprise client dominating revenue.

Name

Instituto de Oncologia do Paraná

Legal name

Instituto de Oncologia do Paraná

Website

https://iop.com.br

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

101–250 employees

Short description

Instituto de Oncologia do Paraná is a private oncology clinic founded in 1995 in Curitiba, Brazil, operating four facilities that deliver chemotherapy, surgical oncology, radiotherapy, hematology, palliative care, and clinical research to cancer patients in Paraná and Southern Brazil.

Ownership category

akta.pro rank

Product category

Oncology Healthcare Services

NAICS

Offices of Physicians (62111), Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Medical and Diagnostic Laboratories (62151)

SIC

Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)

akta.pro primary industry

Ambulatory Oncology Centers (Outpatient Chemo/Radiation) (HLAFABAI)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Oncology & Cancer Specialty Hospitals (HLAFAHAC), Surgical Oncology (HLAKAFAG)

Keywords

• Oncology treatment services
• Chemotherapy care
• Radiotherapy services
• Hematology oncology
• Cancer surgery

Headquarters

HQ city

Curitiba

HQ country

Brazil

HQ region

Latin America

Offices4 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Medical Oncology Services: Revenue generated from outpatient consultations, chemotherapy administration, surgical oncology procedures, and radiotherapy treatments across four clinic locations in Curitiba. Services are billed per episode of care or through health insurance (convênios).
2. Clinical Research: Revenue derived from participation in global clinical trials for cancer treatments, providing access to experimental therapies for eligible patients.
3. Health Insurance (Convênios): Contracted services through health insurance providers covering oncology treatments, chemotherapy, surgery, and supportive care.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

Instituto de Oncologia do Paraná is a private cancer treatment center providing comprehensive oncology services across four Curitiba locations, including chemotherapy, surgical oncology, radiotherapy, immunotherapy, targeted therapy, hematology, and palliative care. It also delivers supportive services (oncology nutrition, psycho-oncology, physiotherapy, integrative therapies, oncology pharmacy, oncology nursing) and runs a clinical research center offering access to global oncology trials.

Differentiator

Problem solved

Functional benefit

Brands

• IOP Educa: Education initiative offering oncology courses, specializations, and postgraduate programs in partnership with PUCPR.
• IOP Pesquisa
• IOP Previne
• Oncoville
• Valencis

Products and services

• Chemotherapy (Quimioterapia) Outpatient chemotherapy administration in environments with privacy, rigorous quality and safety standards, and patient comfort, delivered across IOP's four Curitiba locations.
• Surgical Oncology (Cirurgia Oncológica) Oncological surgical procedures performed at IOP's Centro de Tratamento de Câncer (CTC) and within Hospital São Marcelino Champagnat, supporting diagnosis, tumor removal, and comprehensive cancer care.
• Radiotherapy (Radioterapia) Radiotherapy services delivered at the Oncoville center of excellence in Curitiba's Mossunguê neighborhood, following international quality standards for integral and personalized cancer treatment.
• Hematology (Hematologia) Specialized hematology-oncology care for blood cancers and hematologic disorders including leukemia, lymphoma, and myeloma, with integration to Rede Einstein hematology protocols.
• Infusion Therapy for Autoimmune Diseases (Terapia Infusional para Doenças Autoimunes) Infusion therapy with immunobiological agents for patients with autoimmune diseases, targeting specific immunological and inflammatory pathways in a specialized oncology care setting.
• Clinical Oncology (Oncologia Clínica) Core clinical oncology specialty covering systemic cancer treatment including chemotherapy, immunotherapy, targeted therapy, and hormonal therapy, delivered by a multidisciplinary corpo clínico.
• Mastology (Mastologia) Mastology specialty covering breast cancer screening, diagnosis, surgical treatment, mastectomy, immediate reconstruction, chemotherapy, radiotherapy, hormone therapy, and long-term follow-up.
• Palliative Medicine (Medicina Paliativa) Palliative medicine services delivered through the Valencis institution, providing medical care to patients in palliative care settings and supporting their families.
• Oncology Nutrition (Nutrição Oncológica) Specialized nutrition services for cancer patients as part of IOP's integral support program to support treatment outcomes.
• Psycho-Oncology (Psico-Oncologia) Psychological support services for cancer patients and families across all stages of the oncology journey, provided as part of integral supportive care.
• Oncology Physiotherapy (Fisioterapia Oncológica) Oncology physiotherapy rehabilitation services for cancer patients as part of IOP's integral support program.
• Integrative Therapies (Terapias Integrativas) Integrative and complementary therapies offered to cancer patients to support wellbeing during and after treatment.
• Oncology Pharmacy (Farmácia Oncológica) Specialized oncology pharmacy services supporting chemotherapy preparation, dispensing, and medication management for cancer patients.
• Oncology Nursing (Enfermagem Oncológica) Specialized oncology nursing services delivering clinical care for cancer patients across IOP's locations.
• Clinical Research Center (Centro de Pesquisa IOP) In-house clinical research center participating in global oncology clinical trials, providing eligible patients with access to experimental cancer treatments not yet approved in Brazil.
• IOP Educa - Postgraduate Program in Multiprofessional Oncology (Lato Sensu) A 16-month semi-presential postgraduate Lato Sensu program in Multiprofessional Oncology offered through IOP Educa in partnership with Pontifícia Universidade Católica do Paraná (PUCPR) for nurses, nutritionists, biomedical scientists, psychologists, and physiotherapists.
• Cancer Prevention Program (IOP Previne) Cancer prevention program operated as IOP's wholly owned sub-brand, offering prevention, screening, and early detection initiatives for the community.

Quantifiable outcome

• ONA 3 accreditation - the highest level of health certification in Brazil, reflecting commitment to innovation and quality in oncology treatment.
• +2 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered core.

• Pontifícia Universidade Católica do Paraná (PUCPR)coreStrategic or Co-development Partner · 9 May 2025IOP Educa, IOP's educational initiative, partnered with PUCPR to offer a Post-Graduation in Multiprofessional Oncology (Lato Sensu). The partnership combines IOP's clinical oncology expertise with PUCPR's academic methodology and reputation, offering a 16-month semipresential course for healthcare professionals. Classes are held at PUCPR campus on alternating Fridays (18h-22h) and Saturdays (8h-17h), with the second module providing immersive practical experience in IOP's clinical areas.
• Rede Einstein de Oncologia e Hematologia (Hospital Israelita Albert Einstein)coreStrategic or Co-development PartnerIOP is the first clinic in Southern Brazil to integrate the Rede Einstein de Oncologia e Hematologia network. This partnership provides access to Hospital Albert Einstein's oncology and hematology treatment protocols, quality standards, and best practices. IOP shares the same philosophy of care and safety in cancer treatment as the Einstein network, enhancing the credibility and quality of IOP's oncology services in Paraná.
• Hospital São Marcelino ChampagnatcoreStrategic or Co-development PartnerIOP operates a dedicated Cancer Center (Câncer Center IOP) within Hospital São Marcelino Champagnat, providing integrated oncology services within a full-service hospital setting. This partnership enables IOP to offer surgical oncology, chemotherapy, and comprehensive cancer care within the hospital environment.

Scale indicators6 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Oncoclínicas (Grupo Oncoclínicas): Largest private oncology network in Brazil, aggregating specialty oncology clinics across multiple states — competes with IOP at the broader specialty-oncology-platform level and represents the most likely national consolidator of regional players like IOP.
• Hospital Israelita Albert Einstein: Brazil's leading tertiary hospital and the parent of the Rede Einstein network that IOP is integrated with — comparable as a high-end oncology provider, and a partner whose strategic posture materially affects IOP's positioning.
• Hospital Sírio-Libanês: Premium São Paulo-based general hospital with a strong oncology center — competes for high-end oncology patients nationally and provides an alternative affiliation template similar to IOP's Einstein relationship.
• Rede D'Or São Luiz: Brazil's largest private hospital network offering oncology services across its units — competes broadly for oncology patients and physician talent, and represents a potential acquirer/partner for regional oncology specialists.

Direct peers

• Hospital de Câncer de Barretos: High-volume cancer hospital in São Paulo state with broad oncology specialties, clinical research, and education programs — comparable to IOP as a multi-modality oncology provider with research and teaching arms.
• Hospital Erasto Gaertner: Major oncology hospital also based in Curitiba, offering chemotherapy, radiotherapy, and surgical oncology with a long-standing reputation in Paraná — IOP's most direct head-to-head competitor in its home market.
• AC Camargo Cancer Center: Brazil's flagship comprehensive cancer center in São Paulo, offering multidisciplinary oncology services across medical, surgical, and radiation oncology with an embedded clinical research program — directly comparable to IOP's integrated oncology platform.
• A.C. Camargo: Included to capture overlap with the broader A.C. Camargo ecosystem of cancer care, education, and research — comparable to IOP as a research-active, education-integrated oncology institution.

Regional players

• Hospital Pequeno Príncipe: Major pediatric hospital in Curitiba with oncology services — overlaps with IOP as a Paraná-based institutional healthcare provider and potential partner for pediatric oncology referrals.
• Hospital Mãe de Deus: Premium hospital in Porto Alegre (Rio Grande do Sul) with an established oncology service line — comparable to IOP as a Southern Brazil high-end oncology provider, though operating in a different state.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UC8E8vGU5Vkm7q2PllkechTQ
• Facebookfacebook.com/institutodeoncologiadoparana
• LinkedInlinkedin.com/company/institutodeoncologiadoparana
• Instagraminstagram.com/institutodeoncologiadoparana

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Instituto de Oncologia do Paraná